Matches in Wikidata for { <http://www.wikidata.org/entity/Q93102345> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q93102345 description "article scientifique publié en 2019" @default.
- Q93102345 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q93102345 description "im Juni 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93102345 description "scientific article published on 01 June 2019" @default.
- Q93102345 description "wetenschappelijk artikel" @default.
- Q93102345 description "наукова стаття, опублікована 1 червня 2019" @default.
- Q93102345 name "A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris" @default.
- Q93102345 name "A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris" @default.
- Q93102345 type Item @default.
- Q93102345 label "A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris" @default.
- Q93102345 label "A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris" @default.
- Q93102345 prefLabel "A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris" @default.
- Q93102345 prefLabel "A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris" @default.
- Q93102345 P1433 Q93102345-4560B523-A995-4087-A588-08812234B0E2 @default.
- Q93102345 P1476 Q93102345-3B7EC892-07DC-41F6-A2C1-B495E025F03E @default.
- Q93102345 P2093 Q93102345-2D294802-764F-4EED-9386-CDFABF368AB1 @default.
- Q93102345 P2093 Q93102345-5B875B5C-B5A2-4950-9B7D-3FD9721AC729 @default.
- Q93102345 P2093 Q93102345-7886B973-0F14-4704-90F3-0AD1AD26AEF4 @default.
- Q93102345 P2093 Q93102345-7E04007D-F44D-4C25-8AD1-01170B8E8D96 @default.
- Q93102345 P2093 Q93102345-8207CF60-C0EC-478B-8D62-97B99E4B1B77 @default.
- Q93102345 P2093 Q93102345-A5F1940B-BF72-42AF-8510-3EDA0DB7BEB8 @default.
- Q93102345 P2093 Q93102345-E2BECB05-8871-44BA-A265-C792DEC0D67A @default.
- Q93102345 P304 Q93102345-891A6B53-0F43-4CD2-BF93-97885EDFA5D4 @default.
- Q93102345 P31 Q93102345-26B6989D-551F-45DB-A21F-1C8B809D6C8C @default.
- Q93102345 P433 Q93102345-63B97CD8-5D50-46E2-BE79-8E41D81BA8C5 @default.
- Q93102345 P478 Q93102345-6F393915-BBC5-4555-BA88-8ABAF68A856B @default.
- Q93102345 P577 Q93102345-97F51613-D9BF-427F-8285-D5526959CABD @default.
- Q93102345 P698 Q93102345-17D2F907-174C-429E-9014-0273D9A5EA99 @default.
- Q93102345 P698 31251546 @default.
- Q93102345 P1433 Q25380091 @default.
- Q93102345 P1476 "A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris" @default.
- Q93102345 P2093 "Emil A. Tanghetti" @default.
- Q93102345 P2093 "Eric Guenin" @default.
- Q93102345 P2093 "Gina Martin" @default.
- Q93102345 P2093 "Lawrence J. Green" @default.
- Q93102345 P2093 "Leon H. Kircik" @default.
- Q93102345 P2093 "Radhakrishnan Pillai" @default.
- Q93102345 P2093 "Susan Harris" @default.
- Q93102345 P304 "542" @default.
- Q93102345 P31 Q13442814 @default.
- Q93102345 P433 "6" @default.
- Q93102345 P478 "18" @default.
- Q93102345 P577 "2019-06-01T00:00:00Z" @default.
- Q93102345 P698 "31251546" @default.